Cameco Co. (NYSE:CCJ) Shares Sold by Geneos Wealth Management Inc.

Geneos Wealth Management Inc. reduced its position in shares of Cameco Co. (NYSE:CCJ) (TSE:CCO) by 2.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 10,510 shares of the basic materials company’s stock after selling 240 shares during the period. Geneos Wealth Management Inc.’s holdings in Cameco were worth $453,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Allworth Financial LP boosted its stake in Cameco by 1,049.2% during the third quarter. Allworth Financial LP now owns 747 shares of the basic materials company’s stock worth $30,000 after buying an additional 682 shares during the period. Janiczek Wealth Management LLC boosted its stake in Cameco by 210.4% during the third quarter. Janiczek Wealth Management LLC now owns 773 shares of the basic materials company’s stock worth $31,000 after buying an additional 524 shares during the period. Tyler Stone Wealth Management purchased a new position in Cameco during the second quarter worth about $32,000. Versant Capital Management Inc purchased a new position in Cameco during the fourth quarter worth about $34,000. Finally, 1832 Asset Management L.P. boosted its stake in Cameco by 61.9% during the first quarter. 1832 Asset Management L.P. now owns 1,700 shares of the basic materials company’s stock worth $49,000 after buying an additional 650 shares during the period. 70.21% of the stock is currently owned by institutional investors and hedge funds.

Cameco Stock Down 1.7 %

Shares of Cameco stock opened at $49.59 on Friday. Cameco Co. has a 52-week low of $25.11 and a 52-week high of $52.64. The company has a 50 day moving average of $43.64 and a 200 day moving average of $43.26. The company has a quick ratio of 0.97, a current ratio of 1.55 and a debt-to-equity ratio of 0.21. The company has a market capitalization of $21.53 billion, a P/E ratio of 82.65 and a beta of 0.92.

Cameco (NYSE:CCJ) (TSE:CCO) last issued its quarterly earnings results on Thursday, February 8th. The basic materials company reported $0.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.06). Cameco had a return on equity of 5.61% and a net margin of 13.97%. The firm had revenue of $620.00 million during the quarter. As a group, research analysts forecast that Cameco Co. will post 1.55 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. The Goldman Sachs Group assumed coverage on shares of Cameco in a research note on Monday, April 1st. They set a “buy” rating and a $55.00 target price for the company. StockNews.com lowered shares of Cameco from a “hold” rating to a “sell” rating in a research note on Thursday, April 4th. Finally, Cantor Fitzgerald lowered shares of Cameco from a “buy” rating to a “neutral” rating in a research note on Tuesday, December 19th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, two have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Cameco currently has an average rating of “Moderate Buy” and an average target price of $62.75.

About Cameco

Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.